Home
Magna Scientia Advanced Biology and Pharmacy
Peer-Reviewed • ISSN: 2582-8363 • Fast-Track Publishing • Impact Factor 8.6 • Low Publication Charges • Crossref DOI Linking

Main navigation

  • Home
    • Journal Information
    • Editorial Board Members
    • Abstracting and Indexing
    • Journal Policies
    • Our CrossMark Policy
    • Publication Ethics
    • Issue in Progress
    • Current Issue
    • Past Issues
    • Instructions for Authors
    • Article processing fee
    • Track Manuscript Status
    • Get Publication Certificate
    • Join Editorial Board
    • Join Reviewer Panel
  • Contact us
  • Downloads

Research and review articles are invited for publication in September - October 2026 (Volume 19, Issue 1) Submit manuscript

HIV-1 p24 antigen, HIV-1 protease and expression of HIV-1 Gag-Pol genes amongst HIV-1 Infected individuals in Federal Medical Centre, Lokoja, Nigeria.

Breadcrumb

  • Home
  • HIV-1 p24 antigen, HIV-1 protease and expression of HIV-1 Gag-Pol genes amongst HIV-1 Infected individuals in Federal Medical Centre, Lokoja, Nigeria.

Emeje Paul Isaac 1, *, Oladipe Tunmise Tope 2, Onoja-Alexander Mary Ojonema 3, Yahaya Shehu 4 and Obajemu Babatunde Samuel 5

1 Department of Medical Laboratory Science, Faculty of Allied Health Sciences, Federal University Lokoja, Kogi State, Nigeria.
2 Department of Biochemistry, Confluence University of Science and Technology Osara, Kogi State, Nigeria.
3 Department of Community Medicine, Faculty of Clinical Sciences, College of Health Sciences, Federal University Lokoja, Nigeria.
 4 Department of Bioprocessing, Biotechnology Development Agency Abuja, Nigeria.
 5 Department of Chemical Pathology, Federal Teaching Hospital, Lokoja, Kogi State, Nigeria.
Research Article
Magna Scientia Advanced Biology and Pharmacy, 2024, 13(01), 085–094
Article DOI: 10.30574/msabp.2024.13.1.0058
DOI url: https://doi.org/10.30574/msabp.2024.13.1.0058
Received on 14 August 2024; revised on 28 September 2024; accepted on 30 September 2024
This study is aimed at expressing HIV-1 Pol and Gag genes in the monitoring of HIV-1 patients on HAART in Federal Medical Centre, Lokoja, Kogi State, Nigeria, that randomly recruited 75 participants within the age range of 18 and 65 years with a population- based sample of males and females divided into three groups designated A to C; comprising of 25 HIV-1 seropositive individuals on HAART (TDF + 3TC + EFV) designated as group A, 25 HIV-1 seropositive individuals on HAART (AZT + 3TC +NVP) designated as group B, and 25 HAART naïve HIV-1 seropositive individuals designated as control group C. Blood samples were taken and analyzed using ELISA for p24 antigen, HIV-1 protease and reverse transcription-polymerase chain reaction for HIV-1 Gag-Pol genes. The PCR products were analyzed on 1% agarose gel electrophoresis. Data were analyzed using SPSS software application (version 25.0) and expressed as mean ± standard error of mean. The results showed a significant difference in p24 antigen and HIV-1 protease in group A (9.64 ± 5.34 and 5.48 ± 6.62) when compared to control (16.3 ± 3.68 and 26.68 ± 11.71) (p<0.05). There was also a significant difference in p24 antigen and HIV-1 protease in group B (13.01 ± 5.19 and 20.47 ±7.53) when compared to control (16.3 ± 3.68 and 26.68 ± 11.71) (p<0.05). The gene expression of HIV-1 Pol is broadly expressed compared to the HIV-1 Gag gene expression. The negative Gag expression could be due to decrease in p24 antigen as the antibody increases.
HIV-1 POL; HIV-1 GAG; HIV-1 P24; HIV-1 Protease; HAART
https://msabp.magnascientiapub.com/sites/default/files/fulltext_pdf/MSABP-2024-…

Preview Article PDF

Emeje Paul Isaac, Oladipe Tunmise Tope, Onoja-Alexander Mary Ojonema, Yahaya Shehu and Obajemu Babatunde Samuel. HIV-1 p24 antigen, HIV-1 protease and expression of HIV-1 Gag-Pol genes amongst HIV-1 Infected individuals in Federal Medical Centre, Lokoja, Nigeria.. Magna Scientia Advanced Biology and Pharmacy, 2024, 13(1), 085-094. Article DOI: https://doi.org/10.30574/msabp.2024.13.1.0058

Copyright © Author(s). All rights reserved. This article is published under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, sharing, adaptation, distribution, and reproduction in any medium or format, as long as appropriate credit is given to the original author(s) and source, a link to the license is provided, and any changes made are indicated.


All statements, opinions, and data contained in this publication are solely those of the individual author(s) and contributor(s). The journal, editors, reviewers, and publisher disclaim any responsibility or liability for the content, including accuracy, completeness, or any consequences arising from its use.

Get Certificates

Get Publication Certificate

Download LoA

Check Corssref DOI details

Issue details

Issue Cover Page

Editorial Board

Table of content

Copyright © 2026 Magna Scientia Advanced Biology and Pharmacy - All rights reserved

Developed & Designed by VS Infosolution